{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:54:28Z","timestamp":1783385668431,"version":"3.54.6"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infection, Genetics and Evolution"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.meegid.2017.05.026","type":"journal-article","created":{"date-parts":[[2017,6,2]],"date-time":"2017-06-02T16:00:36Z","timestamp":1496419236000},"page":"195-198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Role of IL28B genotype in the liver stiffness increase in untreated patients with chronic hepatitis C"],"prefix":"10.1016","volume":"53","author":[{"given":"Lucio","family":"Boglione","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Cusato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Cariti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Di Perri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"D'Avolio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.meegid.2017.05.026_bb0005","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jhep.2010.03.022","article-title":"Common variation of IL28 affects gamma-GTP levels and inflammation of the liver in chronically infected hepatitis C virus patients","volume":"53","author":"Abe","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.meegid.2017.05.026_bb0010","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/hep.24678","article-title":"IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes","volume":"55","author":"Bochud","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.meegid.2017.05.026_bb0015","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.antiviral.2014.03.016","article-title":"Identification of naive HVC-4 patients who may be treated with pegylated-interferon and ribavirin according to IL28B polymorphisms","volume":"106","author":"Boglione","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.meegid.2017.05.026_bb0020","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.antiviral.2015.01.014","article-title":"Treatment optimization of naive HCV-1 patients using IL28B, RVR and fibrosis stage","volume":"116","author":"Boglione","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.meegid.2017.05.026_bb0025","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000448332","article-title":"The role of IL28B genotype in HCV-RNA baseline levels","volume":"59","author":"Boglione","year":"2016","journal-title":"Intervirology"},{"key":"10.1016\/j.meegid.2017.05.026_bb0030","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1056\/NEJM200102153440706","article-title":"Liver biopsy","volume":"344","author":"Bravo","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.meegid.2017.05.026_bb0035","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2147\/PPA.S30111","article-title":"Patterns and predictors of treatment initiation and completion in patients with chronic hepatitis C virus infection","volume":"6","author":"Clark","year":"2012","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.meegid.2017.05.026_bb0040","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1365-2893.2006.00811.x","article-title":"Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases","volume":"14","author":"Coco","year":"2007","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.meegid.2017.05.026_bb0045","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jhep.2010.07.019","article-title":"IL-28B rs12979860 C\/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC","volume":"54","author":"Fabris","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.meegid.2017.05.026_bb0050","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s10875-011-9547-1","article-title":"Role of interleukin 28B rs12979860 C\/T polymorphism on the histological outcome of chronic hepatitis C: relationship with gender and viral genotype","volume":"31","author":"Falleti","year":"2011","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.meegid.2017.05.026_bb0055","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1053\/j.gastro.2008.01.034","article-title":"Performance of transient elastography for the staging of liver fibrosis: a meta-analysis","volume":"134","author":"Friedrich-Rust","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.meegid.2017.05.026_bb0060","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.jhep.2009.07.008","article-title":"Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin","volume":"51","author":"Grasso","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.meegid.2017.05.026_bb0065","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1517\/14656560903468710","article-title":"Treatment of chronic hepatitis C in elderly patients","volume":"11","author":"Horsmans","year":"2010","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.meegid.2017.05.026_bb0070","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1053\/j.gastro.2006.03.014","article-title":"Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data","volume":"130","author":"Leandro","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.meegid.2017.05.026_bb0075","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/hep.24503","article-title":"Genetic variation in the interleukin-28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection","volume":"54","author":"Marabita","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.meegid.2017.05.026_bb0080","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1002\/hep.26506","article-title":"Association of IL28B genotype with fibrosis progression and clinical outcomes in patients with chronic hepatitis C: a longitudinal analysis","volume":"58","author":"Noureddin","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.meegid.2017.05.026_bb0085","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1086\/498512","article-title":"Hepatitis C virus infection in African Americans","volume":"42","author":"Pearlman","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.meegid.2017.05.026_bb0090","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1053\/j.gastro.2007.06.059","article-title":"HCV-specific T-cell response in relation to viral kinetics and treatment outcome (DITTO-HCV project)","volume":"133","author":"Pilli","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.meegid.2017.05.026_bb0095","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/S0140-6736(98)07124-4","article-title":"Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT)","volume":"352","author":"Poynard","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.meegid.2017.05.026_bb0100","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0168-8278(00)00097-0","article-title":"Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c","volume":"34","author":"Poynard","year":"2001","journal-title":"J. Hepatol."},{"key":"10.1016\/j.meegid.2017.05.026_bb0105","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/hep.23842","article-title":"Risk factors for infection during treatment with peginterferon alfa and ribavirin for chronic hepatitis C","volume":"52","author":"Roomer","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.meegid.2017.05.026_bb0110","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/hep.21791","article-title":"Hepatitis C treatment in \"difficult-to-treat\" psychiatric patients with pegylated interferon-alpha and ribavirin: response and psychiatric side effects","volume":"46","author":"Schaefer","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.meegid.2017.05.026_bb0115","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/ng.447","article-title":"IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy","volume":"41","author":"Suppiah","year":"2009","journal-title":"Nat. Genet."},{"issue":"383\u2013398","key":"10.1016\/j.meegid.2017.05.026_bb0120","first-page":"vi","article-title":"Natural history of hepatitis C","volume":"9","author":"Thomas","year":"2005","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.meegid.2017.05.026_bb0125","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature08463","article-title":"Genetic variation in IL28B and spontaneous clearance of hepatitis C virus","volume":"461","author":"Thomas","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.meegid.2017.05.026_bb0130","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jhep.2010.07.033","article-title":"Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy","volume":"54","author":"Tsochatzis","year":"2011","journal-title":"J. Hepatol."}],"container-title":["Infection, Genetics and Evolution"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134817301879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134817301879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T05:39:35Z","timestamp":1535780375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567134817301879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":26,"alternative-id":["S1567134817301879"],"URL":"https:\/\/doi.org\/10.1016\/j.meegid.2017.05.026","relation":{},"ISSN":["1567-1348"],"issn-type":[{"value":"1567-1348","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of IL28B genotype in the liver stiffness increase in untreated patients with chronic hepatitis C","name":"articletitle","label":"Article Title"},{"value":"Infection, Genetics and Evolution","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.meegid.2017.05.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}